Unicycive Therapeutics Inc [NASDAQ: UNCY] price surged by 2.06 percent to reach at $0.01.
The one-year UNCY stock forecast points to a potential upside of 92.3. The average equity rating for UNCY stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Unicycive Therapeutics Inc [UNCY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNCY shares is $6.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNCY stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Unicycive Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 04, 2024.
UNCY Stock Performance Analysis:
Unicycive Therapeutics Inc [UNCY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.23. With this latest performance, UNCY shares dropped by -37.36% in over the last four-week period, additionally sinking by -47.75% over the last 6 months – not to mention a drop of -61.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNCY stock in for the last two-week period is set at 35.40, with the RSI for the last a single of trading hit 38.48, and the three-weeks RSI is set at 34.77 for Unicycive Therapeutics Inc [UNCY]. The present Moving Average for the last 50 days of trading for this stock 0.8192, while it was recorded at 0.4758 for the last single week of trading, and 0.9242 for the last 200 days.
Insight into Unicycive Therapeutics Inc Fundamentals:
Unicycive Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.71 and a Current Ratio set at 1.71.
Unicycive Therapeutics Inc [UNCY] Institutonal Ownership Details
The top three institutional holders of UNCY stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in UNCY stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in UNCY stock with ownership which is approximately 5.1238%.
